We are looking to engage people who have had Type 2 diabetes for at least 3 years and who are on a stable treatment regime but showing protein in their urine.

They will have an HbA1C of less than 10%

This trial runs for 16 weeks and there will be 8 site visits. Two of these visits are long days (approx. 7 hours) and will require the patient to have a cannula inserted in a vein for frequent blood testing. The other 6 site visits will require a blood test. An ECG (heart-tracing) will be done twice during the study.